<DOC>
	<DOCNO>NCT02600806</DOCNO>
	<brief_summary>A clinical protocol develop management adult outpatient community-acquired pneumonia ( CAP ) Pneumonia Severity Index risk class I-II . Patients assign oral azithromycin levofloxacin accord procalcitonin ( PCT ) level measure rapid point-of-care method . When PCT level &lt; 0.5 ng/ml , azithromycin , 500 mg/day give orally 5 day ; PCT ≥0.5 ng/ml , levofloxacin , 500 mg/day give orally 7 day</brief_summary>
	<brief_title>Clinical Pathway Based Procalcitonin Levels Management Community-acquired Pneumonia Outpatients</brief_title>
	<detailed_description>A clinical protocol develop collaboration hospital 's Emergency Department management adult outpatient community-acquired pneumonia ( CAP ) . Patients assign 2 treatment category accord plasma procalcitonin ( PCT ) value . Treatment assignment : 1 . PCT &lt; 0.5 ng/ml : azithromycin , 500 mg/day orally 5 day 2 . PCT≥0.5ng/ml : levofloxacin , 500 mg/day orally 7 day Laboratory microbiological study : In ED , patient sign symptom pneumonia blood sample collect routine biochemical hematological determination , PCT concentration measurement . Rapid test determination PCT perform BRAHMS PCT-Q , immunochromatografic test semi-quantitative detection PCT serum ( BRAHMS GmbH , 16761 Hennigsdorf , Germany ) . PCT concentration range follow : &lt; 0.5 ng/ml ; ≥ 0.5 ng/ml ; ≥2 ng/ml ; ≥10 ng/ml . The etiological diagnostic workup include obtain sputum sample patient productive cough , urine sample detection S. pneumoniae Legionella pneumophila serogroup 1 antigen immunochromatographic assay ( Binax NOW , Alere Healthcare SLU , Spain ) . Only qualify sputum sample , define accord standard criterion ( presence &gt; 25 WBC &lt; 10 squamous cell per low-power magnification field [ x10 ] ) evaluate . Serum sample ( obtain acute stage illness 4 week later ) collect frozen -80ºC ulterior serological testing . An indirect chemiluminescent immunoassay ( VirClia® Monotest , Vircell , S.L. , Granada , Spain ) perform detect IgG antibody Mycoplasma pneumoniae , Chlamydophila pneumoniae , Legionella pneumophila Coxiella burnetii . Calculation cutoff value interpretation result perform accordance instruction manufacturer . The diagnostic criterion either seroconversion ( index value negative positive ) significant increase index value ( ≥threefold ) pair sample . All assay perform analyzed blindly person . Follow-up outcome measure : After treatment assign , patient refer outpatient clinic , see within follow 24 hour ( Visit 2 ) . A phone visit ( Visit 3 ) schedule day 7 , last programmed visit day 30 clinic ( Visit 4 ) . Patients instructed visit outpatient ' clinic clinical status worsen fever persist 48 hour first visit . Cure define improvement lack progression baseline radiographic finding end therapy ( EOT ) resolution sign , include chest X-Ray , symptom pneumonia visit 4 . Failure define persistence progression sign symptom progression radiological sign pneumonia EOT , persistent infiltrate X-Ray visit 4 , initiation within 2 calendar day initial antibiotic therapy different potentially effective antibiotic , death day 3 attributable primary infection , relapse infection visit 4 . Antibiotic change requirement due toxicity , need hospital admission also record . In addition short-term outcome , long-term ( 3-year ) outcome patient assess structured telephone interview .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Fever without respiratory symptom New infiltrate chest radiograph Pneumonia Severity Index ( PSI ) score ≤ 70 ( risk class I II ) . PSI risk class IIIV Age ≥65 year Comorbidity ( diabetes , chronic obstructive pulmonary disease , chronic renal disease , neoplasia , immunosuppression include HIV infection , chronic heart failure cirrhosis ) White blood cell count ≥20.0 x 109/L Pleural effusion Bilateral infiltrate Previous failure allergy macrolides quinolones Need oxygen therapy</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Community-acquired pneumonia</keyword>
	<keyword>Procalcitonin</keyword>
	<keyword>Outpatients</keyword>
	<keyword>Outcomes</keyword>
	<keyword>Azithromycin</keyword>
	<keyword>Fluoroquinolones</keyword>
</DOC>